Skip to main content
TipRanks
Go Ultimate75% OFF

ABIONYX Pharma SA (ABNX) Income Statement

7 Followers

ABIONYX Pharma SA Income Statement

Last quarter (Q2 2026), ABIONYX Pharma SA's total revenue was €1.93M, a decrease of 17.53% from the same quarter last year. In Q2, ABIONYX Pharma SA's net income was €-4.81M. See ABIONYX Pharma SA’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
€ 4.06M€ 4.60M€ 4.64M€ 5.25M€ 675.00K
€ 376.00K€ 844.00K€ 618.00K€ 636.00K€ 259.00K
€ 6.63M€ 5.31M€ 4.03M€ 4.75M€ 6.21M
Depreciation and Amortization€ 551.00K€ 135.00K€ 153.00K€ 135.00K€ 119.00K
€ -5.70M€ -5.27M€ -4.53M€ -4.01M€ -7.42M
€ -6.25M€ -5.57M€ -3.41M€ -4.11M€ -5.95M
€ 17.00K€ 84.00K€ -106.00K€ -97.00K€ 130.00K
€ -6.24M€ -5.47M€ -3.52M€ -4.21M€ -5.82M
€ -5.55M€ -4.40M€ -3.52M€ -4.21M€ -5.82M
Per Share Metrics
Basic EPS€ -0.16€ -0.13€ -0.12€ -0.15€ -0.23
Diluted EPS€ -0.16€ -0.13€ -0.12€ -0.15€ -0.23
Weighted Average Shares Outstanding35.51M33.70M29.35M27.97M24.88M
Weighted Average Shares Outstanding (Diluted)35.51M33.70M29.35M27.97M24.88M

Currency in EUR

ABIONYX Pharma SA Earnings and Revenue History

-12M-6M06M-4500 %-3000 %-1500 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin